Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Vasovic LV, DeSimone RA. Increase in Google search interest for paid plasma donation in the United States during and after the great recession. Transfusion. 2019;59(10):3056-3057.

Nuovo G, Schwartz Z, Magro C. A comparison of the detection of biomarkers in infections due to low risk versus high-risk human papillomavirus types. Ann Diagn Pathol. 2019;41:57-61.

Nellis ME, Goel R, Karam O, Cushing MM, Davis PJ, Steiner ME, et al. Effects of ABO Matching of Platelet Transfusions in Critically Ill Children. Pediatr Crit Care Med. 2019;20(2):e61-e69.

Sun Q, Welsh KJ, Bruns DE, Sacks DB, Zhao Z. Inadequate Reporting of Analytical Characteristics of Biomarkers Used in Clinical Research: A Threat to Interpretation and Replication of Study Findings. Clin Chem. 2019;65(12):1554-1562.

Wallach AI, Magro CM, Franks AG, Shapiro L, Kister I. Protean Neurologic Manifestations of Two Rare Dermatologic Disorders: Sweet Disease and Localized Craniofacial Scleroderma. Curr Neurol Neurosci Rep. 2019;19(3):11.

Lau BW, Huh K, Madero-Marroquin R, De Marchi F, Lim Y, Wang Q, et al. Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity. Oncogene. 2019;38(5):687-698.

Zadra G, Ribeiro CF, Chetta P, Ho Y, Cacciatore S, Gao X, et al. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2019;116(2):631-640.

Vlachostergios PJ, Geyer JT, Miller J, Kosloff R, Beltran H, Tagawa ST. Exceptional Response to Pembrolizumab in a Patient With Castration-Resistant Prostate Cancer With Pancytopenia From Myelophthisis. J Oncol Pract. 2019;15(6):343-345.

Nakanishi Y, Diaz-Meco MT, Moscat J. Serrated Colorectal Cancer: The Road Less Travelled? Trends Cancer. 2019;5(11):742-754.

Geyer JT. Myeloid Neoplasms with Germline Predisposition. Pathobiology. 2019;86(1):53-61.